ESR1 and breast carcinoma: Specifically, experimental studies confirm that 4-NP acts as an agonist of estrogen receptor α (ERα) in MCF-7 human breast cancer cells, thereby promoting estrogenic signaling pathways implicated in breast carcinogenesis [18].